唾液蛋白质组预测非手术治疗牙周炎预后的生物标志物
治疗显著降低出血评分、探诊深度≥5mm位点百分比、菌斑和牙龈指数,并调控唾液蛋白质组,提示唾液生物标志物可用于监测治疗结局。
要点
- 非手术牙周治疗可显著改善临床指标并改变唾液蛋白质组。
- 治疗后1个月和6个月分别有80和118种人源蛋白表达调控。
- 小脯氨酸富集蛋白3和淋巴细胞特异性蛋白1是变化最显著的人源蛋白。
核心结论
- 牙周治疗降低临床疾病参数,这些变化反映在唾液蛋白质组中,提示唾液生物标志物可作为监测治疗结局的预后工具。
研究设计与样本
- 在治疗前(T0)、治疗后1个月(T1)和6个月(T6)采集唾液,共30份样本。
- 采用非标记定量蛋白质组学分析唾液蛋白质组,蛋白质表达变化随时间建模,显著性阈值设为错误发现率<0.05。
主要发现
- 治疗显著降低出血评分、探诊深度≥5mm位点百分比、菌斑指数和牙龈指数。
- T1 vs. T0有80种人源蛋白调控(60上调,20下调);T6 vs. T0有118种人源蛋白调控(67上调,51下调)。
- T6与T1相比唾液蛋白质组保持稳定;治疗后蛋白质活性最高的是细胞运动和炎症反应。
- 小脯氨酸富集蛋白3(T1 vs. T0:5.4倍上调)和淋巴细胞特异性蛋白1(T6 vs. T0:4.6倍下调)是变化最显著的人源蛋白;黏膜奈瑟菌和Socranskii密螺旋体蛋白(T1 vs. T0:分别8.0倍和4.9倍下调)下调。
临床怎么用
- 唾液蛋白质组变化与临床指标改善同步,可作为无创监测牙周治疗反应的潜在工具。
- 治疗后1个月和6个月的人源蛋白调控模式不同,提示生物标志物动态需按时间点解读。
局限性
- 研究为观察性前瞻设计,未验证唾液生物标志物的预测效能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: This prospective study investigated the salivary proteome before and after periodontal therapy. MATERIALS AND METHODS: Ten systemically healthy, non-smoking, stage III, grade C periodontitis patients underwent non-surgical periodontal treatment. Full-mouth periodontal parameters were measured, and saliva (n = 30) collected pre- (T0), and one (T1) and six (T6) months post-treatment. The proteome was investigated by label-free quantitative proteomics. Protein expression changes were modelled over time, with significant protein regulation considered at false discovery rate <0.05. RESULTS: Treatment significantly reduced bleeding scores, percentages of sites with pocket depth ≥5 mm, plaque and gingival indexes. One thousand seven hundred and thirteen proteins were identified and 838 proteins (human = 757, bacterial = 81) quantified (≥2 peptides). At T1, 80 (T1 vs. T0: 60↑:20↓), and at T6, 118 human proteins (T6 vs. T0: 67↑:51↓) were regulated. The salivary proteome at T6 versus T1 remained stable. Highest protein activity post- versus pre-treatment was observed for cellular movement and inflammatory response. The small proline-rich protein 3 (T1 vs. T0: 5.4-fold↑) and lymphocyte-specific protein 1 (T6 vs. T0: 4.6-fold↓) were the top regulated human proteins. Proteins from Neisseria mucosa and Treponema socranskii (T1 vs. T0: 8.0-fold↓, 4.9-fold↓) were down-regulated. CONCLUSIONS: Periodontal treatment reduced clinical disease parameters and these changes were reflected in the salivary proteome. This underscores the potential of utilizing saliva biomarkers as prognostic tools for monitoring treatment outcomes.
引用
- Silbereisen A, Bao K, Wolski W, et al. Probing the salivary proteome for prognostic biomarkers in response to non-surgical periodontal therapy. J Clin Periodontol. 2024. PMID: 38660744. doi:10.1111/jcpe.13990
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。